Enterprise AI Analysis

The LEGION Workflow: AI-Driven Chemical Space Exploration

The LEGION (Latent Enumeration, Generation, Integration, Optimization, and Navigation) workflow represents a paradigm shift in drug discovery, enabling massive coverage of chemical space around specific drug targets like NLRP3. It integrates advanced generative AI and AI-guided screening within the Chemistry42 platform, significantly expanding beyond traditional compound libraries.

This multi-stage process leverages both 3D structure-based drug design (SBDD) and 2D enumeration techniques, ensuring both binding relevance and synthetic accessibility for the generated compounds. Key innovations include 3D pharmacophore-aware scaffold extraction and a combinatorial expansion approach for unparalleled chemical diversity.

Unprecedented Chemical Space Coverage for NLRP3

The LEGION workflow successfully identified over 34,000 unique scaffolds aligned with 3D spatial binding hypotheses, leading to the generation of approximately 110 million chemical structures. The provided code further enables the generation of up to 123 billion molecular structures, demonstrating an "incalculably large coverage" specifically tailored to the NLRP3 target.

This vast dataset bridges the gap between 2D generative models and meaningful 3D chemical space exploration, ensuring binding relevance and structural validity. It offers significant advantages for scaffold hopping, chemical space navigation, and strengthening intellectual property portfolios through structurally diverse and synthetically accessible compounds.

While some general-purpose chemical spaces are larger, LEGION's unique advantage lies in its *target-oriented* generation, ensuring high relevance and tractability for specific drug targets, unlike the sparse coverage offered by broad, untargeted libraries.

Robust Validation of Virtual Hit Rates

To ensure the practical value of the generated chemical space, extensive technical validation was performed through 3D SBDD virtual screening. This involved extrapolating virtual hit rates from randomized samples of the enumerated library.

The 2D Generative Chemistry Workflow demonstrated over 60% extrapolation to 3D virtual hits, highlighting the high fidelity of the generated structures. Combinatorial approaches showed hit rates ranging from 8% to 26%, confirming the workflow's effectiveness in generating credible potential drug candidates.

Accelerating Drug Discovery & Securing IP

The LEGION NLRP3 datasets are invaluable for large-scale virtual screening, enabling the identification of novel and diverse NLRP3 inhibitor chemotypes. The methodology supports both retrospective and prospective studies for validating its capabilities.

Such capabilities are critical for modern drug development, offering opportunities for scaffold hopping, identifying patentable regions within chemical space, and driving the discovery of first-in-class molecules like NLRP3 inhibitors.